Copyright © 2000 by the European Society of Cardiology.
Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty
Division of Cardiology, Department of Internal Medicine, National Cardiovascular Centre, Suita, Osaka, Japan
revised March 21, 2000; accepted March 21, 2000
Abstract
Aims We sought to find out what factors are important for long-term prognosis, the small vessel itself or abnormal glucose tolerance, in patients treated with coronary angioplasty.
Background Patients with coronary artery disease with diabetes mellitus often show diffuse and small cornary artery narrowing. Impaired glucose tolerance has also been reported to be a risk factor for cardiovascular disease.
Methods Among 584 patients who underwent first elective balloon coronary angioplasty, diabetes mellitus and impaired glucose tolerance were present in 197 patients. Large and small vessels were defined by reference vessel diameter before coronary angioplasty as either larger or smaller than 2·5mm. Patients were categorized into the following four groups: 175 patients with normal glucose tolerance and reference diameter <2·5mm (group SN), 212 patients with normal glucose tolerance and reference diameter 
2·5mm (group LN), 101 patients with abnormal glucose tolerance and reference diameter <2·5mm (group SD), and 96 patients with abnormal glucose tolerance and reference diameter 2·5mm (Group LD). The cardiac events were compared for a period of 8 years after coronary angioplasty among the four groups.
Results There was no difference in the percentage diameter stenosis immediately after coronary angioplasty among the four groups. However, group SD showed unfavourable prognosis despite similar minimal lumen diameter after coronary angioplasty compared with group SN. Event-free survival curve of group LD showed a sudden drop approximately 5 years after the coronary angioplasty. In multivariate analysis, the cardiac events were associated with the presence or absence of abnormal glucose tolerance. Furthermore, patients with bad glycaemic control (HbA1c>6·0%) at index coronary angioplasty showed worse event free survival than those with good glycaemic control.
Conclusions An important determinant for long-term prognosis after coronary angioplasty is a presence of abnormal glucose tolerance per se and not small vessel diameter.
Key Words: Small vessel disease, balloon angioplasty, abnormal glucose tolerance, cardiac event
f1 Correspondence: Shunichi Miyazaki, MD, PhD, FACC, Division of Cardiology, Department of Internal Medicine, National Cardiovascular Centre, Fujishirodai 5-7-1, Suita, Osaka, 565-8465, Japan.
References
- Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 1993;21:15–25[Abstract]
- Topol EJ, Leya F, Pinkerton CA. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease: the CAVEAT Study Group. N Engl J Med. 1993;329:221–227
[Abstract/Free Full Text] - Rensing BJ, Hermans WR, Deckers JW, de Feyter PJ, Tijssen JG, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1445 successfully dilated lesions. J Am Coll Cardiol. 1992;19:939–945[Abstract]
- Beatt KJ, Serruys PW, Luijten HE. Restenosis after coronary angioplasty: the paradox of increased lumen diameter and restenosis. J Am Coll Cardiol. 1992;19:258–266[Abstract]
- Anonymous. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217–225
[Abstract/Free Full Text] - Weintraub WS, Jones EL, Morris DC, King SB III, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868–877
[Abstract/Free Full Text] - Morris JJ, Smith LR, Jones RH. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991;84:275–284
- Stein B, Weintraub WS, Gebhart SSP. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979–989
[Abstract/Free Full Text] - Kip KE, Faxon DP, Detre KM, Yeh WL, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients—The National Heart, Lung, and Blood Institute percutaneous transluminal corollary angioplasty registry. Circulation. 1996;94:1818–1825
[Abstract/Free Full Text] - Howard G, O’Leary DH, Zaccaro D. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809–1817
[Abstract/Free Full Text] - Anonymous. Diabetes mellitus. Report of a WHO Study Group. World Health Org Tech Rep Ser. 1985;727:1–113
- Anonymous. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Group. N Engl J Med. 1993;329:977–986
[Abstract/Free Full Text] - Clarkson P, Celermajer DS, Donald AE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 1996;28:573–579[Abstract]
- McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA. 1992;89:8150–8154
[Abstract/Free Full Text] - Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA. 1993;90:6434–6438
[Abstract/Free Full Text] - Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science. 1988;240:1546–1548
[Abstract/Free Full Text] - Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun. 1992;187:552–560[CrossRef][ISI][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M Bartnik, L Ryden, K Malmberg, J Ohrvik, K Pyorala, E Standl, R Ferrari, M Simoons, J Soler-Soler, and on behalf of the Euro Heart Survey Investigators Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart Heart, January 1, 2007; 93(1): 72 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Poirier, T. D. Giles, G. A. Bray, Y. Hong, J. S. Stern, F. X. Pi-Sunyer, and R. H. Eckel Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 968 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Poirier, T. D. Giles, G. A. Bray, Y. Hong, J. S. Stern, F. X. Pi-Sunyer, and R. H. Eckel Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation, February 14, 2006; 113(6): 898 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Mak and D. P. Faxon Clinical studies on coronary revascularization in patients with type 2 diabetes Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cisowski, J. Drzewiecki, A. Drzewiecka-Gerber, A. Jaklik, W. Kruczak, M. Szczeklik, and A. Bochenek Primary stenting versus MIDCAB: preliminary report-Comparision of two methods of revascularization in single left anterior descending coronary artery stenosis Ann. Thorac. Surg., October 1, 2002; 74(4): S1334 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.S. Elkeles Blood glucose and coronary heart disease Eur. Heart J., November 1, 2000; 21(21): 1735 - 1737. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||